All Categories
    Menu Close


    HealthMode, Inc. ( powers next-generation clinical trials and works toward regulatory approval and market access for drugs, devices, and combination products by developing and delivering AI-enabled digital measurement methods for clinical trials and clinical care.

    HealthMode’s client partners represent a diverse set of stakeholders including drug developers at large pharmaceutical companies, clinical researchers and practitioners at academic medical centers, and startups entering the space with novel capabilities.

    HealthMode’s measurement techniques:
    - Improve understanding of phenotype
    - Streamline and provide assurance for screening and eligibility;
    - Provide early detection and mitigation of adverse events; and
    - Serve as sensitive, specific, objective, and low burden endpoints.

    The HealthMode approach allows for meaningful integration of clinical trial data with real-world evidence and provides the basis for movement toward a patient-specific understanding of health and wellness.

    View as Grid List
    Sort by
    Display per page
    Picture of HealthMode digital clinical measures

    HealthMode digital clinical measures

    HealthMode develops digital clinical measures for low-friction, continuous data collection in real-world settings that provide precise information for outcome analysis and decision making for clinical trials and health care.
    Call for pricing